A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Brexpiprazole D8 | CAS 1427049-19-1 - Request Quote

Picture of Brexpiprazole D8

Brexpiprazole D8

SZ CAT No:SZ-B011D01
CAS No
1427049-19-1
Mol.F.
C25H19D8N3O2S
Mol.Wt.
441.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Brexpiprazole D8 is chemically 7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy-1,1,2,2,3,3,4,4-d8)quinolin-2(1H)-one. Brexpiprazole D8 is supplied with detailed characterization data compliant with regulatory guideline. Brexpiprazole D8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Brexpiprazole.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1427049-19-1

Purchase 1427049-19-1

Order 1427049-19-1

Enquire 1427049-19-1

price of 1427049-19-1

1427049-19-1 Supplier

1427049-19-1 Manufacturer

1427049-19-1 Exporter

buy high quality Brexpiprazole D8

Purchase Brexpiprazole D8

Brexpiprazole D8 suppliers

Brexpiprazole D8 manufacturers

Brexpiprazole D8 price

Order Brexpiprazole D8

Enquire Brexpiprazole D8

Brexpiprazole D8 cost

Brexpiprazole D8 Supplier

Brexpiprazole D8 Distributor

Brexpiprazole D8 for Method Validation

Brexpiprazole Reference Standard

Brexpiprazole D8 for ANDA Filing

Brexpiprazole D8 for Forced Degradation Studies

Brexpiprazole D8 Identification Standards

Brexpiprazole D8 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,